May 31
Corrections: Abbott says TriLipix adds to Crestor cholesterol benefit
A MarketWatch report on Abbott Laboratories’ TriLipix drug misstated the stand-alone drug in the comparison for bad cholesterol reduction. The study showed that bad cholesterol was reduced an average of up to 39% using a combination of TriLipix and Crestor, compared with about 7% using TriLipix alone.